Predictions
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.95
25.09.23
25.09.23
€9.44
25.09.24
25.09.24
-2.42%
26.09.24
26.09.24
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€34.40
25.09.23
25.09.23
€107.74
25.09.24
25.09.24
48.26%
26.09.24
26.09.24
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€83.00
25.09.23
25.09.23
€131.92
25.09.24
25.09.24
-24.36%
26.09.24
26.09.24
Kezar Life Sciences
Start price
Target price
Perf. (%)
€1.05
25.09.23
25.09.23
€18.82
25.09.24
25.09.24
-56.19%
26.09.24
26.09.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
-3.38%
24.09.24
24.09.24
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.00
23.09.23
23.09.23
-
23.09.24
23.09.24
-22.75%
24.09.24
24.09.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€188.80
22.09.23
22.09.23
€257.73
22.09.24
22.09.24
-1.59%
23.09.24
23.09.24
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.02
21.09.23
21.09.23
-
21.09.24
21.09.24
-7.27%
01.10.23
01.10.23
Could be very worthwhile Investment >20% year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€1.25
20.09.23
20.09.23
-
20.09.24
20.09.24
-24.48%
02.10.23
02.10.23
Could be worthwhile Investment >10% per year
Precision BioSciences Inc
Start price
Target price
Perf. (%)
€0.39
19.09.23
19.09.23
€2.81
19.09.24
19.09.24
-11.92%
20.09.24
20.09.24
First Wave BioPharma Inc.
Start price
Target price
Perf. (%)
€3.95
19.09.23
19.09.23
€10.29
19.09.24
19.09.24
0.00%
20.09.24
20.09.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€48.20
19.09.23
19.09.23
€64.47
19.09.24
19.09.24
-48.36%
20.09.24
20.09.24
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€23.20
19.09.23
19.09.23
€21.49
19.09.24
19.09.24
37.93%
20.09.24
20.09.24
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.80
19.09.23
19.09.23
€44.85
19.09.24
19.09.24
-16.10%
20.09.24
20.09.24
Amgen Inc.
Start price
Target price
Perf. (%)
€246.80
19.09.23
19.09.23
€250.00
19.09.24
19.09.24
4.13%
27.09.23
27.09.23
Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€533.50
19.09.23
19.09.23
€558.00
19.09.24
19.09.24
6.56%
11.10.23
11.10.23
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market